CN
Search...
About Us
Group Overview
Management Team
Milestones of Chipscreen
Group Honors
Social Responsibility
Core Technologies and R&D
Core Technologies
Scientific Committee
R&D System
Drug Lifecycle Management
Pipeline
Pipelines
News & Events
Company News
Media Coverage
Notices & Announcements
Video Library
Investors
Company Announcements
Periodic Reports
Career Development
Contact Us
Contact Details
CN
EN
News & Events
Chipscreen Highlights: Stay Updated on Recent Hot Topics
Home
News & Events
Company News
Media Coverage
Notices & Announcements
Video Library
Select year
2026
2025
2024
2023
2022
Earlier
shown/page
5
5
10
15
20
2025.10.15
ESMO 2025 | Study Results on Chidamide's HDACi+IO Strategy Selected for Proffered Paper Session
ESMO 2025 | Study Results on Chidamide's HDACi+IO Strategy Selected for Proffered Paper Session
Full text
2025.09.25
Leading with Source Innovation: Chipscreen Biosciences and Chiglitazar Sodium (Bilessglu®) Honored with A Decade of Glory for China's Innovative Drugs Awards
Leading with Source Innovation: Chipscreen Biosciences and Chiglitazar Sodium (Bilessglu®) Honored with A Decade of Glory for China's Innovative Drugs Awards
Full text
2025.08.18
Chipscreen Biosciences 2025 Innovation Summit Concludes Successfully: AI + Integrated Core Technology Platform Fuels Original New Drug Development
Chipscreen Biosciences 2025 Innovation Summit Concludes Successfully: AI + Integrated Core Technology Platform Fuels Original New Drug Development
Full text
2025.08.07
International Hepatology Journal Publishes Key Study on Chiglitazar Sodium (Bilessglu®) for MASH Treatment
International Hepatology Journal Publishes Key Study on Chiglitazar Sodium (Bilessglu®) for MASH Treatment
Full text
2025.07.31
Chipscreen Biosciences' Brain-Penetrant Aurora B Selective Inhibitor CS231295 Tablet Receives FDA IND Approval, Advancing Global Clinical Development
Chipscreen Biosciences' Brain-Penetrant Aurora B Selective Inhibitor CS231295 Tablet Receives FDA IND Approval, Advancing Global Clinical Development
Full text
03
04
05
...
24
Media contact
（+86）0755-36993500
pr@juliucq.com
